Aurelia de Pauw
Corporate Officer/Principal presso TETRA BIO-PHARMA INC.
Posizioni attive di Aurelia de Pauw
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| TETRA BIO-PHARMA INC. | Corporate Officer/Principal | 01/10/2018 | - |
TALLC Corp., Inc.
 TALLC Corp., Inc. Pharmaceuticals: MajorHealth Technology TALLC Corp, Inc. operates as a pre-clinical stage pharmaceutical company. It focuses on the development of TA-A001, a novel endocannabinoid CB2 receptor activator with potent anti-inflammatory analgesic properties. The company was founded by Damon Smith, Melanie Kelly and Guy Chamberland and is headquartered in Laval, Canada. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Aurelia de Pauw
Formazione di Aurelia de Pauw
| Faculté Universitaire des Sciences Agronomiques de Gembloux | Graduate Degree |
| Université de Namur ASBL | Doctorate Degree |
Statistiche
Distribuzione geografica
| Canada | 3 |
| Belgio | 3 |
Posizioni
| Corporate Officer/Principal | 1 |
| Graduate Degree | 1 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| TETRA BIO-PHARMA INC. | Health Technology |
| Aziende private | 1 |
|---|---|
TALLC Corp., Inc.
TALLC Corp., Inc. Pharmaceuticals: MajorHealth Technology TALLC Corp, Inc. operates as a pre-clinical stage pharmaceutical company. It focuses on the development of TA-A001, a novel endocannabinoid CB2 receptor activator with potent anti-inflammatory analgesic properties. The company was founded by Damon Smith, Melanie Kelly and Guy Chamberland and is headquartered in Laval, Canada. | Health Technology |
- Borsa valori
- Insiders
- Aurelia de Pauw
- Esperienza